Abbot Financial Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$249K Buy
+208
New +$213K 0.09% 130
2026
Q1
Sell
-208
Closed -$224K 139
2025
Q4
$224K Buy
+208
New +$199K 0.09% 129
2024
Q4
Sell
-228
Closed -$202K 129
2024
Q3
$202K Hold
228
0.1% 123
2024
Q2
$206K Buy
+228
New +$182K 0.11% 119
2021
Q1
Sell
-328
Closed -$55K 144
2020
Q4
$55K Hold
328
0.03% 133
2020
Q3
$49K Hold
328
0.03% 124
2020
Q2
$54K Hold
328
0.04% 120
2020
Q1
$46K Hold
328
0.04% 115
2019
Q4
$43K Buy
+328
New +$38K 0.03% 128

Other funds holding LLY

Abbot Financial Management's LLY Position: Q2 2026 in Review

Abbot Financial Management opened a new position in Eli Lilly (LLY) in Q2 2026: 208 shares worth $249K. The stake represents 0.09% of the portfolio and ranks #130 among its holdings. This is a return to the name: Abbot Financial Management previously reported a position in LLY as recently as Q4 2025.

Abbot Financial Management first reported a position in LLY in Q4 2019 and has held it in 9 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Abbot Financial Management held 208 shares of Eli Lilly worth $249K as of Q2 2026.
  • Eli Lilly was a new Abbot Financial Management position in Q2 2026.
  • Eli Lilly made up 0.09% of Abbot Financial Management's portfolio in Q2 2026, its #130 holding.
  • Abbot Financial Management first reported a position in Eli Lilly in Q4 2019 and has held it in 9 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Abbot Financial Management's 13F filing for Q2 2026, filed 6 Aug 2026.